U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 2728

1.
Response to Kahler, Janda, Soyer, et al.
David C Whiteman, Catherine M Olsen, Nirmala Pandeya, Philip S Rosenberg
J Natl Cancer Inst. 2024 Apr; 116(4): 626. Published online 2024 Jan 16. doi: 10.1093/jnci/djae007
PMCID:
PMC11494235
ArticlePDF–235K
2.
Correction to: Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer
J Natl Cancer Inst. 2023 Nov; 115(11): 1431. Published online 2023 Aug 11. doi: 10.1093/jnci/djad161
Corrects:
J Natl Cancer Inst. 2023 Jun; 115(6): 753–756.
PMCID:
PMC11494221
CorrectionPDF–73K
3.
Developing the next-generation cancer research workforce in the National Institutes of Health Intramural Research Program
Nina F Schor
J Natl Cancer Inst. 2024 May; 116(5): 637–641. Published online 2024 Jan 25. doi: 10.1093/jnci/djae017
PMCID:
PMC11491838
AbstractArticlePDF–857K
4.
Maximizing scarce colonoscopy resources: the crucial role of stool-based tests
Gloria D Coronado, Leslie Bienen, Andrea Burnett-Hartman, Jeffrey K Lee, Carolyn M Rutter
J Natl Cancer Inst. 2024 May; 116(5): 647–652. Published online 2024 Feb 4. doi: 10.1093/jnci/djae022
PMCID:
PMC11491837
AbstractArticlePDF–3.1M
5.
Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis
Yukio Suzuki, Jennifer S Ferris, Ling Chen, Shayan Dioun, John Usseglio, Koji Matsuo, Xiao Xu, Dawn L Hershman, Jason D Wright
J Natl Cancer Inst. 2024 May; 116(5): 653–664. Published online 2024 Feb 1. doi: 10.1093/jnci/djae023
PMCID:
PMC11491835
AbstractArticlePDF–1.6M
6.
Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancer
Dipesh Uprety, Randell Seaton, Tarik Hadid, Hirva Mamdani, Ammar Sukari, Julie J Ruterbusch, Ann G Schwartz
J Natl Cancer Inst. 2024 Oct; 116(10): 1697–1704. Published online 2024 Jun 3. doi: 10.1093/jnci/djae118
PMCID:
PMC11461161
AbstractArticlePDF–1.0M
7.
Correction to: Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer
J Natl Cancer Inst. 2024 Oct; 116(10): 1705. Published online 2024 Aug 30. doi: 10.1093/jnci/djae206
Corrects:
J Natl Cancer Inst. 2021 Sep; 113(9): 1246–1257.
PMCID:
PMC11461160
CorrectionPDF–179K
8.
Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers
Tram Kim Lam, Phil Daschner, Naoko Ishibe, Anil Wali, Kara Hall, Susan Czajkowski, Somdat Mahabir, Joanna M Watson, Linda Nebeling, Sharon Ross, Edward Sauter
J Natl Cancer Inst. 2024 Oct; 116(10): 1555–1561. Published online 2024 Jun 17. doi: 10.1093/jnci/djae134
PMCID:
PMC11461156
AbstractArticlePDF–502K
9.
Editor’s Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex
J Natl Cancer Inst. 2024 Aug; 116(8): 1409. Published online 2024 Jul 11. doi: 10.1093/jnci/djae168
Expression of Concern about:
J Natl Cancer Inst. 2013 Mar 20; 105(6): 405–423.
PMCID:
PMC11308180
ArticlePDF–173K
10.
When the somatic genome informs the germline: the example of TP53
Payal P Khincha, Sharon A Savage
J Natl Cancer Inst. 2024 Aug; 116(8): 1190–1192. Published online 2024 Jun 22. doi: 10.1093/jnci/djae126
PMCID:
PMC11308161
ArticlePDF–316K
11.
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
Elisa Fontana, Ezra Rosen, Elizabeth K Lee, Martin Højgaard, Niharika B Mettu, Stephanie Lheureux, Benedito A Carneiro, Gregory M Cote, Louise Carter, Ruth Plummer, Devalingam Mahalingam, Adrian J Fretland, Joseph D Schonhoft, Ian M Silverman, Marisa Wainszelbaum, Yi Xu, Danielle Ulanet, Maria Koehler, Timothy A Yap
J Natl Cancer Inst. 2024 Sep; 116(9): 1439–1449. Published online 2024 May 6. doi: 10.1093/jnci/djae098
PMCID:
PMC11378309
AbstractArticlePDF–808K
12.
Executing plans to enhance diversity across cancer centers in the United States: opportunities and challenges
Christopher I Li, Sherise Chantell Rogers, Carol J Bult, Carmen E Guerra, Angela Talton, Lovoria B Williams, Wendy Law
J Natl Cancer Inst. 2024 Aug; 116(8): 1198–1205. Published online 2024 May 6. doi: 10.1093/jnci/djae100
PMCID:
PMC11308197
AbstractArticlePDF–626K
13.
The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review
Alexandra Gilbert, Robert Samuel, Daniel Cagney, David Sebag-Montefiore, Julia Brown, Sarah R Brown
J Natl Cancer Inst. 2024 Aug; 116(8): 1220–1229. Published online 2024 Apr 27. doi: 10.1093/jnci/djae084
PMCID:
PMC11308198
AbstractArticlePDF–1.2M
14.
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening
Hormuzd A Katki, Philip C Prorok, Philip E Castle, Lori M Minasian, Paul F Pinsky
J Natl Cancer Inst. 2024 Aug; 116(8): 1280–1287. Published online 2024 Apr 11. doi: 10.1093/jnci/djae083
Retraction in:
J Natl Cancer Inst. 2024 Sep 12
PMCID:
PMC11308171
AbstractArticle
15.
Evaluating colonoscopy quality by performing provider type
Emily Berry, Jeff Hostetter, Joseph Bachtold, Sarah Zamarripa, Keith E Argenbright
J Natl Cancer Inst. 2024 Aug; 116(8): 1264–1269. Published online 2024 Apr 8. doi: 10.1093/jnci/djae080
PMCID:
PMC11308165
AbstractArticlePDF–689K
16.
Targeting fusion oncoproteins in childhood cancers: challenges and future opportunities for developing therapeutics
Sharad K Verma, Keren L Witkin, Anu Sharman, Malcolm A Smith
J Natl Cancer Inst. 2024 Jul; 116(7): 1012–1018. Published online 2024 Apr 4. doi: 10.1093/jnci/djae075
PMCID:
PMC11223828
AbstractArticlePDF–590K
17.
Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management
Laurel P Gibson, Rebecca A Ferrer, Salimah H Meghani, Amanda M Acevedo
J Natl Cancer Inst. 2024 Jul; 116(7): 1019–1025. Published online 2024 Mar 12. doi: 10.1093/jnci/djae058
PMCID:
PMC11223862
AbstractArticlePDF–495K
18.
Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome
Yurong Song, Holli Loomans-Kropp, Ryan N Baugher, Brandon Somerville, Shaneen S Baxter, Travis D Kerr, Teri M Plona, Stephanie D Mellott, Todd B Young, Heidi E Lawhorn, Lei Wei, Qiang Hu, Song Liu, Alan Hutson, Ligia Pinto, John D Potter, Shizuko Sei, Ozkan Gelincik, Steven M Lipkin, Johannes Gebert, Matthias Kloor, Robert H Shoemaker
J Natl Cancer Inst. 2024 Jun; 116(6): 957–965. Published online 2024 Mar 11. doi: 10.1093/jnci/djae060
Correction in:
J Natl Cancer Inst. 2024 Sep; 116(9): 1535.
PMCID:
PMC11160491
AbstractArticlePDF–765K
19.
Prediagnostic evaluation of multicancer detection tests: design and analysis considerations
Stuart G Baker, Ruth Etzioni
J Natl Cancer Inst. 2024 Jun; 116(6): 795–799. Published online 2024 Feb 28. doi: 10.1093/jnci/djae050
PMCID:
PMC11160505
AbstractArticlePDF–390K
20.
Outdoor air pollution exposure and uterine cancer incidence in the Sister Study
Jordyn A Brown, Jennifer L Ish, Che-Jung Chang, Deborah B Bookwalter, Katie M O’Brien, Rena R Jones, Joel D Kaufman, Dale P Sandler, Alexandra J White
J Natl Cancer Inst. 2024 Jun; 116(6): 948–956. Published online 2024 Feb 12. doi: 10.1093/jnci/djae031
PMCID:
PMC11160506
AbstractArticlePDF–671K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center